Neogenomics Inc
NEO- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001077183
In the last 90 days, Neogenomics Inc insiders filed 0 open-market purchases and 1 sale; 266 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Neogenomics Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 287
- +6 vs. Q3 2023
- Shares held
- 125.8M
- +5.48M (+4.6%) vs. Q3 2023
- Total value
- $2.04B
- +$555.4M (+37.5%) vs. Q3 2023
- New holders
- 41
- 87 more added
- Sold out
- 35
- 98 more reduced
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 266 | $2.11B |
| Q1 2026 | 253 | $995.3M |
| Q4 2025 | 257 | $1.54B |
| Q3 2025 | 254 | $995.4M |
| Q2 2025 | 274 | $930.2M |
| Q1 2025 | 256 | $1.20B |
| Q4 2024 | 253 | $2.02B |
| Q3 2024 | 270 | $1.82B |
| Q2 2024 | 259 | $1.74B |
| Q1 2024 | 263 | $2.02B |
| Q4 2023 | 287 | $2.04B |
| Q3 2023 | 284 | $1.48B |
| Q2 2023 | 267 | $1.89B |
| Q1 2023 | 257 | $2.02B |
| Q4 2022 | 244 | $1.04B |
| Q3 2022 | 246 | $969.0M |
| Q2 2022 | 240 | $956.4M |
| Q1 2022 | 281 | $1.36B |
| Q4 2021 | 309 | $4.02B |
| Q3 2021 | 325 | $5.58B |
| Q2 2021 | 313 | $5.03B |
| Q1 2021 | 332 | $5.21B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Neogenomics Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Verition Fund Management LLC | 0 | $0 | 0.00% | −21,225−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −18,620−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −17,840−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −16,207−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −13,232−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −12,851−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,765−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,285−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −10,816−100.0% | Sold out |
| Texas Capital Bank Wealth Management Services Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,200−100.0% | Sold out |
| BluePath Capital Management, LLC | 0 | $0 | 0.00% | −2,407−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −983−100.0% | Sold out |
| Contravisory Investment Management, Inc. | 0 | $0 | 0.00% | −940−100.0% | Sold out |
| American National Bank | 0 | $0 | 0.00% | −304−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −224−100.0% | Sold out |
| Raleigh Capital Management Inc. | 0 | $0 | 0.00% | −191−100.0% | Sold out |
| Legacy Financial Group LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Headinvest, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Advisor Partners II, LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |